Nanoparticles for providing immune responses against infectious agents
US8895023B2 · kind B2 · utility
25Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 22, 2013 |
| Grant date | Nov 25, 2014 |
| Priority date | — |
| Expiry date | Apr 22, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nanoparticles for providing immune responses for the treatment or prophylaxis of infection by infectious agents such as viruses, parasites, bacteria, prions and fungi are described which comprises a core including metal and/or semiconductor atoms, wherein the core is covalently linked to a plurality of ligands, the ligands including a carbohydrate residue capable of stimulating an innate immune response, a T cell helper peptide and a danger signal. This platform may then be adapted by including one or more further ligands capable of producing a specific response to a target infectious agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.